Download Citation
Article Source:
Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients
Cao Y,
Xiao G,
Qiu X,
Ye S,
Lin T
(2014)
Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients.
PLOS ONE 9(12): e114008.
https://doi.org/10.1371/journal.pone.0114008